From latest Ann: "The company plans to initiate Phase 1b/2 clinical trial of PTX-100 in multiple myeloma in H1 2015.".
But yes, you're correct, PTX-200 is currently in Phase 1b/2. But this is one drug, two trials.
I'll also correct myself...its Co-X-gene technology.
Time to shine PTX, page-4
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
-0.001(2.50%) |
Mkt cap ! $32.21M | |||
| Open | High | Low | Value | Volume |
| 4.0¢ | 4.0¢ | 3.9¢ | $10.55K | 269.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 757841 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 647611 | 1 |
View Market Depth
| Last trade - 15.30pm 20/11/2024 (20 minute delay) ? |
| PTX (ASX) Chart |
